º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

Executives of leading Welsh diagnostics firm getting £2m bonuses

Chief executive of EKF Diagnostics Julian Baines will stand down from the role in October

EKF chief executive Julian Baines will stand down in October

Standing down executive directors at one of Wales' leading life sciences sector firms, EKF Diagnostics , are getting final cash bonuses of £2m in recognition of significant shareholder value created over the last five years.

The remuneration committee of Alternative Investment Market listed EKF Diagnostics, which has its HQ in Penarth, has agreed £2m bonuses to chief executive Julian Baines, who will stand down in October, and chief operating officer and finance director, Richard Evans, who will stand down in June, 2022.

The incentive executive bonus scheme for the global point-of-care diagnostics company was previously based on an exit through an acquisition by a third party.

However, the board have approved it now being assessed against shareholder value created.

The total performance in EKF's share price since the inception of the incentive scheme (set up in June 2016) represents a gain of 56.45p per share. Moreover, further value created from EKF's relationship with US-based Mount Sinai Innovation Partners is equivalent to 54.85p per EKF share.

The latter has seen a number of successful spinout firms from EKF including Verici and Renalytix.

Last year, buoyed in part by the manufacturing Covid 19 sample collection tests, EKF posted record turnover and profits.

It recently upgraded expectations for 2021 with its core business trading strongly and securing a multi-million dollar contract expansion for the supply of sample collection devices to a large multinational customer.